<div dir="ltr"><div dir="ltr"><span id="m_-5654700342234366369gmail-docs-internal-guid-7fba9f1a-7fff-bd34-385e-916fca66a844"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:11pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">(Apologies for cross-posting)</span></p><br><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:10pt;margin-bottom:10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-il">Final CFP</span>: <span class="gmail-il">SYMPTEMIST</span> Shared Task (BioCreative VIII run with AMIA 2023) </span></p><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">NER and entity linking of symptoms</span></p><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:0pt;margin-bottom:0pt;padding:0pt 0pt 10pt"><a href="https://temu.bsc.es/distemist/" target="_blank" style="text-decoration-line:none"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline">https://temu.bsc.es/<span class="gmail-il">SYMPTEMIST</span>/</span></a></p><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:11pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> </span></p><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:0pt;margin-bottom:0pt;padding:10pt 0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">The <span class="gmail-il">SYMPTEMIST</span> focuses on the detection of mentions of symptoms (NER) and mapping to concept identifiers in clinical case reports in Spanish (entity linking). Also a multilingual version of the dataset will be released including versions in English, French, Italian, Dutch, Portuguese, Romanian and Swedish.</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Key information:</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Web</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: <a href="https://temu.bsc.es/symptemist" target="_blank">https://temu.bsc.es/<span class="gmail-il">symptemist</span></a></span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Data</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">:</span><a href="https://doi.org/10.5281/zenodo.6408476" target="_blank" style="text-decoration-line:none"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> </span></a><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(17,85,204);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline"><a href="https://zenodo.org/record/8223654" target="_blank">https://zenodo.org/record/8223654</a></span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Annotation guidelines</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: <a href="https://zenodo.org/record/8246440" target="_blank">https://zenodo.org/record/8246440</a></span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative web</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: </span><a href="https://biocreative.bioinformatics.udel.edu/" target="_blank" style="text-decoration-line:none"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline">https://biocreative.bioinformatics.udel.edu</span></a></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Registration form (</span><span style="font-size:10pt;color:rgb(32,33,36);font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 2- <span class="gmail-il">SYMPTEMIST</span></span><span style="font-size:10pt;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">)</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">:</span><a href="https://temu.bsc.es/distemist/registration/" target="_blank" style="text-decoration-line:none"><span style="font-size:10pt;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> </span></a><a href="https://docs.google.com/forms/d/e/1FAIpQLScoSNulOoxRju3c8v9Q-CSv-w5jJcXu93G7A7v343AWfonpPw/viewform" target="_blank" style="text-decoration-line:none"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline">https://docs.google.com/forms/d/e/1FAIpQLScoSNulOoxRju3c8v9Q-CSv-w5jJcXu93G7A7v343AWfonpPw/viewform</span></a></p></li></ul><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:10pt;margin-bottom:0pt;padding:0pt 0pt 10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(17,85,204);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Motivation</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Systems able to detect and normalize clinical symptom mentions from medical texts are crucial for almost any healthcare data mining, AI, medical analytics or predictive application. As opposed to other clinical information types, such as diagnoses (diseases/procedures), lab test results or even medications, clinical symptoms can only be recovered directly from written clinical narratives. Due to the high complexity, variability and difficulty in generating annotated corpora for clinical symptoms, only few large manually annotated data collections have been constructed so far, with certain underlying limitations in terms of a) entity linking / normalization of the symptom mentions to controlled vocabularies and b) a lack of attempts to promote the development of multilingual solutions and b) provide detailed annotation criteria and guidelines. To address these issues, we have posed the <span class="gmail-il">SYMPTEMIST</span> track at the upcoming BioCreative VIII initiative, which will be run in the context of the prestigious AMIA 2023 conference, which received over 1400 submissions this year.</span></p><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:0pt;margin-bottom:10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Automatic detection of symptoms mentions are key for a range of clinical use cases and real world applications like:</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Predictive modeling of diseases</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Differential diagnosis of complex diseases</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Rare disease characterization & analysis</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Selection of appropriate treatment & therapy</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Study of  disease-symptom associations</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Early detection of disease outbreaks & epidemiological surveillance</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Extraction of phenotypes</span></p></li><li dir="ltr" style="margin-left:15px;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Drug repurposing & off label indications </span></p></li></ul><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:12pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">The <span class="gmail-il">SYMPTEMIST</span> organizers will also release multilingual resources to foster the development of multilingual tools and generate systems not only for Spanish but also for content in English and Romance languages (French, Portuguese, Italian, Romanian and Catalan) as well as versions in Dutch, Swedish and Czech.</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:12pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Inspired by previous initiatives (e.g. n2c2, CLEF or TREC) and shared tasks (CANTEMIST, PharmaCoNER, or CodiEsp), we are launching the <span class="gmail-il">SYMPTEMIST</span> shared task as part of the BioCreative 2023 evaluation initiative, with the following three sub-tracks:</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-il">SYMPTEMIST</span>-entities:</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> automatic detection of mentions of symptoms.</span></p></li></ul><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-il">SYMPTEMIST</span>-linking</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: finding mentions of symptoms and normalizing them to their Snomed-CT concept identifiers.</span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-il">SYMPTEMIST</span>-multilingual</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: automatic detection of mentions of symptoms in versions of the corpus generated in English, French, Italian, Portuguese, Romanian, Catalan, Dutch, Swedish and Czech.</span></p></li></ul><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Tentative schedule</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"></p><ul><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">SympTEMIST Annotation Guidelines Release  August 8th 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">SympTEMIST Train Set Subtask 1 (NER) Release August 8th, 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">SympTEMIST Train Set Subtask 2 (Linking) Release    September 12th, 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">SympTEMIST Gazetteer Release    September 12th, 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">SympTEMIST Test Set Release     September 30th 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">Participants Test Predictions Deadline   October 5th 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">Participants Evaluation Results Release     October 10th 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">Submission of Participant Papers Deadline  October 22nd 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">Notification of Acceptance Participant Papers      October 30th 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">Submission of Camera-ready Participant Papers Deadline     November 1st 2023</span></li><li><span style="background-color:transparent;color:rgb(0,0,0);font-family:Calibri,sans-serif;font-size:10pt">BioCreative VIII @ AMIA 2023       November 11-15 2023</span></li></ul><p></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative proceedings and AMIA workshop</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Teams participating in <span class="gmail-il">SYMPTEMIST</span> will be invited to contribute a systems description paper for the BioCreative  2023 Working Notes proceedings and a flash presentation of their approach at the BioCreative 2023 session. The BioCreative VIII workshop will run with AMIA 2023, November 11-15, 2023, In New Orleans, LA. See: <a href="https://amia.org/education-events/amia-2023-annual-symposium" target="_blank">https://amia.org/education-events/amia-2023-annual-symposium</a></span></p><br><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Workshop Proceedings and Special Issue</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">:</span></p><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">The BioCreative VIII Proceedings will host all the submissions from participating teams, and it will be freely available by the time of the workshop. In addition, we are happy to announce that the journal Database will host the BioCreative VIII special issue for work that has passed their peer-review process. Invitation to submit will be sent after the workshop. </span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br><br></span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">All BioCreative VIII tracks</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 1: BioRED (Biomedical Relation Extraction Dataset)</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">*Track 2: <span class="gmail-il">SYMPTEMIST</span> (Symptom TExt Mining Shared Task)</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 3: Genetic Phenotype Extraction and Normalization from Dysmorphology Physical Examination Entries</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 4: Clinical Annotation Tool Track</span></p><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Main Organizers</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Martin Krallinger, Barcelona Supercomputing Center, Spain</span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Eulàlia Farré-Maduell, Barcelona Supercomputing Center, Spain</span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Luis Gascó, Barcelona Supercomputing Center, Spain</span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Salvador Lima, Barcelona Supercomputing Center, Spain</span></p></li><li dir="ltr" style="margin-left:11pt;list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><p dir="ltr" role="presentation" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Jan Rodriguez, Barcelona Supercomputing Center, Spain</span></p></li></ul><br><br></span><div><br></div><div dir="ltr" class="gmail_signature"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div dir="ltr"><div>=======================================<br>Martin Krallinger, Dr.<br><span style="font-family:arial,helvetica,sans-serif">Head of NLP for Biomedical Information Analysis Unit<br></span><span style="font-family:arial,helvetica,sans-serif">Barcelona Supercomputing Center (BSC-CNS)</span></div><div><font face="arial, helvetica, sans-serif"><a href="https://www.linkedin.com/in/martin-krallinger-85495920/" target="_blank">https://www.linkedin.com/in/martin-krallinger-85495920/</a><br></font> =======================================</div></div></div></div></div></div></div></div></div></div></div></div>